Nozomu Yanaihara

5PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Nov 07, 2025
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.

Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa

|Sep 05, 2025
Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.

Nozomu Yanaihara, Ka Yu Tse, Sung Jong Lee

|Jun 12, 2024
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer.

Yuki Kochi, Satoshi Hosoya, Nozomu Yanaihara

|May 26, 2017
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.

Ji Yon Agnes Jang, Nozomu Yanaihara, Eric Pujade-Lauraine

Pageof 1

Frequent Collaborators

3 joint publications

Aikou Okamoto

2 joint publications

Ayako Kawabata

2 joint publications

Kyosuke Yamada

2 joint publications

Hirokuni Takano